International healthcare services provider UDG Healthcare has announced a deal to buy US-based MicroMass Communications for a total consideration of up to $75.8m. 

The US-based healthcare communications agency specialises in behavioural change. It designs solutions across all therapeutic areas that improve patient and health outcomes by changing patient and provider behaviour. 

Under the terms of the deal, MicroMass is being bought for an initial consideration of $63.8m.

An additional consideration of up to $12m will be payable over the next three years, based on the achievement of agreed profit targets. 

MicroMass employs over 100 people at its headquarters in Cary, North Carolina. The existing management team will remain with the business after the deal is completed.

UDG Healthcare's chief executive Brendan McAtamney said that MicroMass provides the company with the ability to strengthen its Ashfield division's presence and capabilities in the US market.

The CEO also said it provides UDG with a platform to expand into the high growth areas of behavioural change and direct patient engagement.

"UDG has now committed more than $275m to acquisitions this financial year, in line with our strategy of expanding into higher growth, higher margin areas, through acquisitions that add further capabilities for our global pharmaceutical client base and are a strong strategic and cultural fit to our existing businesses," Mr McAtamney said.